|
|
|
Yale Biotech Group Hosts Commercialization Forum
|
Business New Haven
9/16/2002
By: BNH
|
NEW HAVEN - The second annual Yale and New Haven Biotechnology Reception, sponsored by the Yale Biotechnology Student Interest Group, a student organization interested in promoting local biotechnology development, will take place on September 20 at 12:30 p.m. at the New Haven Lawn Club.
The conference, titled “Bridging the Gap between Academia and Industry,” will highlight recent accomplishments of local companies and also discuss nationwide trends in biotechnology and the drug-development industry. The event also will explore issues related to the process by which new technologies are brought from the bench to the bedside.
Keynote speakers include Stanley Crooke, founder, chairman and CEO of Isis Pharmaceuticals, widely regarded as a pioneer in the biotechnology industry, and William Rice, founder and CEO of Achillion Pharmaceuticals in New Haven.
A panel discussion addressing the biotech start-up process with perspectives from biotech management, venture capital, intellectual property law and academia will follow the keynote addresses. The complete agenda and registration information can be found at www.yalebiotech.org. The conference is free of charge but registration is required since attendance will be capped.
The Yale Biotechnology Student Interest Group (Biotech SIG), founded in 1998 by graduate students of Yale law, medicine, life sciences and business schools, is a multidisciplinary organization comprising over 500 Yale graduate and professional students. The main components of the Biotech SIG include an interdisciplinary biotechnology curriculum development initiative, a consulting group, an investment analysis group, a speaker series and a career fair.
|
Go FirstGo PreviousGo
NextGo LastGo
to Index
|
|
